Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate
(24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Vlastimil Kunc
- Ahmed Hassen
- Brian Sanders
- Dan Coughlin
- Gerald Tuskan
- Hongbin Sun
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Jim Tobin
- John F Cahill
- Josh Crabtree
- Josh Michener
- Kim Sitzlar
- Liangyu Qian
- Merlin Theodore
- Nate See
- Paul Abraham
- Prashant Jain
- Steven Guzorek
- Subhabrata Saha
- Thien D. Nguyen
- Vilmos Kertesz
- Vipin Kumar
- Xiaohan Yang
- Yang Liu

In nuclear and industrial facilities, fine particles, including radioactive residues—can accumulate on the interior surfaces of ventilation ducts and equipment, posing serious safety and operational risks.

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

A novel approach is presented herein to improve time to onset of natural convection stemming from fuel element porosity during a failure mode of a nuclear reactor.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Through the use of splicing methods, joining two different fiber types in the tow stage of the process enables great benefits to the strength of the material change.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.